From:  The interplay of insulin resistance, glycemic variability, and metabolic dysfunction-associated steatotic liver disease

 Comparison of glycemic and IR assessment methods.

MethodPurposeSample typeTime period reflectedAdvantagesLimitationsClinical useCost and accessibility
Fasting plasma glucose (FPG)Diagnose hyperglycemia and screen for diabetes or impaired fasting glucoseVenous blood (fasting)Single time point (basal glycemia)Simple, inexpensive, widely available; standardized diagnostic thresholdsDoes not capture postprandial excursions or glycemic variability; limited sensitivity for early dysglycemia; influenced by acute stress or illnessInitial screening and diagnosis of diabetes; routine metabolic assessmentVery low cost; universally accessible
Homeostasis model assessment of insulin resistance (HOMA-IR)Estimate IRVenous blood (fasting glucose + fasting insulin)Single time point (fasting state)Simple surrogate of IR; useful in epidemiological studiesNot validated for individual clinical decision-making; influenced by insulin assay variability; limited interpretability across populationsResearch and population studies: an adjunct marker of IRLow–moderate cost; insulin assays may limit availability
Glycated hemoglobin (HbA1c)Assess long-term average glycemic exposure; diagnose and monitor diabetesVenous blood8–12 weeks (integrated mean glycemia)Well standardized; no fasting required; predictive of microvascular complications in diabetesDoes not reflect short-term glucose fluctuations, postprandial hyperglycemia, or hypoglycemia; similar HbA1c values may mask heterogeneous glucose profilesDiagnosis and monitoring of diabetes; risk stratification based on average glycemiaLow–moderate cost; widely available
Oral glucose tolerance test (OGTT)Detect impaired glucose tolerance and characterize post-load glycemic responseVenous blood (fasting and post-glucose load)Short-term dynamic response (0–120 minutes, sometimes extended)Sensitive to early dysglycemia; captures postprandial hyperglycemia not seen with FPG or HbA1c; enables derivation of insulin secretion and sensitivity indicesTime-consuming; poor reproducibility; influenced by acute factors (diet, activity, illness); limited reflection of day-to-day glycemic patterns; impractical for routine follow-upDiagnosis of impaired glucose tolerance and diabetes in selected cases; metabolic phenotyping in researchGlucose tolerance and diabetes in selected cases; metabolic phenotyping in research
Moderate cost; available but limited by logistics
Continuous glucose monitoring (CGM)Characterize real-time glucose dynamics and glycemic variabilityInterstitial glucose via subcutaneous sensorMinutes to days or weeks (diurnal and short-term patterns)Captures postprandial excursions, nocturnal hypoglycemia, and glycemic variability; identifies “hidden” dysglycemia despite normal HbA1c; high temporal resolutionHigher cost; limited access in some settings; requires technical expertise and patient adherence; clinical thresholds outside diabetes are not fully establishedSelected patients with suspected glycemic instability, discordant conventional markers, or for metabolic phenotyping, research applicationsHigh cost; accessibility varies by health system